These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 6416726)
41. IgG subclass recognition pattern in leprosy: recognition of M. leprae antigens by IgG1 and IgG3 antibodies is distinct across the disease spectrum. Kifayet A; Hussain R Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):69-78. PubMed ID: 8627117 [TBL] [Abstract][Full Text] [Related]
42. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851 [TBL] [Abstract][Full Text] [Related]
43. Novel mechanisms in the immunopathogenesis of leprosy nerve damage: the role of Schwann cells, T cells and Mycobacterium leprae. Spierings E; De Boer T; Zulianello L; Ottenhoff TH Immunol Cell Biol; 2000 Aug; 78(4):349-55. PubMed ID: 10947859 [TBL] [Abstract][Full Text] [Related]
44. Use of a whole blood assay to monitor the immune response to mycobacterial antigens in leprosy patients: a predictor for type 1 reaction onset? Weir RE; Butlin CR; Neupane KD; Failbus SS; Dockrell HM Lepr Rev; 1998 Sep; 69(3):279-93. PubMed ID: 9805883 [TBL] [Abstract][Full Text] [Related]
45. Antibody activity against Mycobacterium leprae antigen 7 during the first year of DDS treatment in lepromatous (BL-LL) leprosy. Melsom R; Naafs B; Harboe M; Closs O Lepr Rev; 1978 Mar; 49(1):17-29. PubMed ID: 347205 [No Abstract] [Full Text] [Related]
46. Antibodies against BCG antigen 60 in mycobacterial infection. Harboe M; Closs O; Bjorvatn B; Bjune G Br Med J; 1977 Aug; 2(6084):430-3. PubMed ID: 407965 [TBL] [Abstract][Full Text] [Related]
47. Anti-peripheral nerve antibodies in leprosy patients recognize an epitope shared by the M. leprae 65 kDa heat shock protein. Launois P; N'Diaye M; Sarthou JL; Millan J; Bach MA J Autoimmun; 1992 Dec; 5(6):745-57. PubMed ID: 1283301 [TBL] [Abstract][Full Text] [Related]
48. Deciphering the contribution of lipid droplets in leprosy: multifunctional organelles with roles in Mycobacterium leprae pathogenesis. de Mattos KA; Sarno EN; Pessolani MC; Bozza PT Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():156-66. PubMed ID: 23283467 [TBL] [Abstract][Full Text] [Related]
49. The role of Schwann cells, T cells and Mycobacterium leprae in the immunopathogenesis of nerve damage in leprosy. Spierings E; De Boer T; Zulianello L; Ottenhoff TH Lepr Rev; 2000 Dec; 71 Suppl():S121-9. PubMed ID: 11201869 [TBL] [Abstract][Full Text] [Related]
50. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein. Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355 [TBL] [Abstract][Full Text] [Related]
51. A method for the detection of M. leprae antigens in urine of leprosy patients by gel diffusion and gel electrophoretic techniques and significance in diagnosis. Patil SA; Katoch K; Sengupta U Acta Leprol; 1991; 7(5):403-7. PubMed ID: 1805496 [TBL] [Abstract][Full Text] [Related]
52. T cell response to purified filtrate antigen 85 from Mycobacterium bovis Bacilli Calmette-Guérin (BCG) in leprosy patients. Launois P; Huygen K; De Bruyn J; N'Diaye M; Diouf B; Sarthouj L; Grimaud J; Millan J Clin Exp Immunol; 1991 Nov; 86(2):286-90. PubMed ID: 1934596 [TBL] [Abstract][Full Text] [Related]
53. Demonstration of mycobacterial antigens in skin biopsies fron suspected leprosy cases in the absence of bacilli. Barbosa Júnior Ade A; Silva TC; Patel BN; Santos MI; Wakamatsu A; Alves VA Pathol Res Pract; 1994 Sep; 190(8):782-5. PubMed ID: 7831154 [TBL] [Abstract][Full Text] [Related]
54. Serum Levels of Migration Inhibitory Factor (MIF) and Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M Front Immunol; 2018; 9():246. PubMed ID: 29487601 [TBL] [Abstract][Full Text] [Related]
55. Immunogenicity of Mycobacterium leprae unique antigens in leprosy endemic populations in Asia and Africa. Bobosha K; Van Der Ploeg-Van Schip JJ; Zewdie M; Sapkota BR; Hagge DA; Franken KL; Inbiale W; Aseffa A; Ottenhoff TH; Geluk A Lepr Rev; 2011 Dec; 82(4):445-58. PubMed ID: 22439283 [TBL] [Abstract][Full Text] [Related]
56. Sero-immunoreactivity of cloned protein antigens of Mycobacterium leprae. Khan MB; Deshpande RG; Davidson SK; Navalkar RG Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):195-200. PubMed ID: 1522362 [TBL] [Abstract][Full Text] [Related]
57. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients. Brett SJ; Kingston AE; Colston MJ Clin Exp Immunol; 1987 Jun; 68(3):510-20. PubMed ID: 3308217 [TBL] [Abstract][Full Text] [Related]
58. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules. Bapat CV; Modak MS; DeSouza NG; Chulawalla RG Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823 [TBL] [Abstract][Full Text] [Related]
59. Restoration of proliferative response to M. leprae antigens in lepromatous T cells against candidate antileprosy vaccines. Mustafa AS Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):257-67. PubMed ID: 8862259 [TBL] [Abstract][Full Text] [Related]